Methacrylate-derivatized collagen photocross-linking

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for modifying collagen's mechanical properties are limited by cytotoxicity, lack of control over cross-linking, and preservation of the protein's tertiary structure, making it difficult to create materials with desired mechanical and biofunctional properties for tissue engineering applications.

Innovation Solution

The synthesis of collagen methacrylamide (CMA) with reactive methacrylate groups allows for photocross-linking using UV light, enabling modulation of mechanical properties while preserving the collagen's ability to self-assemble and maintain bioactivity, allowing for the creation of robust, biocompatible hydrogels.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If chemical cross-linking methods (e.g., glutaraldehyde) are used to improve mechanical strength, then strength is improved, but cytotoxicity increases

Engineering Contradiction:
Improvemechanical strengthVSAvoidcytotoxicity
Core Design Contradiction:
StrengthVSObject-affected harmful factors

Solution Approach 1:

The patent replaces chemical cross-linking methods with photocross-linking using UV light and photoinitiators. This substitution eliminates the need for toxic chemical cross-linkers like glutaraldehyde, thereby maintaining mechanical strength improvement while eliminating cytotoxicity. The photocross-linking process uses light energy to activate cross-linking reactions, providing a biocompatible alternative that strengthens collagen without harming cells.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent modifies the cross-linking mechanism by changing from chemical parameters (chemical cross-linkers) to optical parameters (UV light wavelength, intensity, and duration). By controlling these optical parameters, the cross-linking process can be precisely regulated to achieve desired mechanical properties while maintaining cytocompatibility, as the light parameters can be adjusted without introducing toxic substances.

Inventive Principle:
Principle #35Parameter changes

2Strength

If conventional cross-linking methods are used to enhance mechanical properties, then strength is improved, but control over cross-linking spatial distribution is lost

Engineering Contradiction:
Improvemechanical strengthVSAvoidspatial control of cross-linking
Core Design Contradiction:
StrengthVSManufacturing precision

Solution Approach 1:

The patent enables local quality control by using focused light sources (such as lasers or LED arrays) that can be positioned and shaped to cross-link collagen only in specific regions. This allows different areas of the collagen scaffold to have different cross-linking densities, creating spatially varying mechanical properties to match specific tissue requirements, thereby achieving both strength improvement and precise spatial control.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent adds spatial dimensionality control to the cross-linking process by using optical fields that can be patterned in two or three dimensions. Through techniques like confocal laser scanning or projected light patterns, the cross-linking can be controlled not only in depth but also across the surface area, enabling precise three-dimensional control over the cross-linked collagen structure that conventional chemical methods cannot achieve.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Strength

If collagen is modified to improve mechanical properties, then strength is improved, but the protein's tertiary structure and bioactivity are compromised

Engineering Contradiction:
Improvemechanical strengthVSAvoidtertiary structure stability
Core Design Contradiction:
StrengthVSStability of the object's composition

Solution Approach 1:

The patent substitutes chemical modification methods with photocross-linking that operates under milder conditions. By using UV light activation instead of chemical cross-linkers, the collagen's tertiary structure is better preserved as the process avoids harsh chemical environments that would denature the protein. The photocross-linking can be performed at physiological temperatures and pH levels, maintaining collagen's bioactivity while achieving the desired mechanical strengthening.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent employs preliminary action by incorporating photoinitiators into the collagen structure before cross-linking. This allows the cross-linking to be triggered at the desired time and location under controlled conditions, preventing premature structural disruption. The photoinitiators are positioned to activate cross-linking only when exposed to the appropriate wavelength of light, thereby preserving collagen's native structure until the moment of cross-linking is intentionally initiated.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach provides a cytocompatible method to create mechanically tunable collagen hydrogels that can be used in tissue engineering, offering controlled spatial modulation of material properties and improved performance in scaffolds for tissue regeneration and repair.

Implementation Method 1

The synthesis of collagen methacrylamide (CMA) with reactive methacrylate groups allows for photocross-linking using UV light

Methodology Applied
Scientific EffectPhotopolymerisation: Photopolymerisation

Implementation Method 2

CMA is able to self-assemble from a liquid macromer solution into a fibrillar hydrogel at physiological pH and temperature

Methodology Applied
Scientific EffectSelf-assembly: Self-Assembly

Data Source

PatentUS8658711B2Process for the synthesis of methacrylate-derivatized type-1 collagen and derivatives thereof
Publication Date: 2014.02.25 RUTGERS THE STATE UNIV
  • US8658711B2 patent drawing
  • US8658711B2 patent drawing
  • US8658711B2 patent drawing

AI summary

Methods for synthesizing a methacrylate-derivatized type-I collagen in which methacrylic acid is reacted with a carboxylic acid activating reagent in the presence of a carbodiimide to form a methacrylic acid with an activated carboxylic acid group, which is then reacted with free amino groups on type-I collagen to form a collagen methacrylamide. Methacrylate-derivatized collagen, cross-linked collagens formed therefrom and products containing the cross-linked collagen are also disclosed.